Biosense
Vendor:
First CVE: Jun 1, 2021 · Active for 5 years
2
Total CVEs
More Total CVEs than 49% of tracked products
2.0
Avg CVEs / Year
Higher CVE frequency than 60% of tracked products
6.0
Avg CVSS
Higher Avg CVSS than 20% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Biosense over time
Volume of CVEsAvg CVSS Base Score
First CVE
Jun 1, 2021
5 years ago
Most Recent CVE
Jun 1, 2021
1,882 days ago
CVE Severity & Scoring
Biosense2 CVEs
100%
All CVEs352,785 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network2 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low2 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (50.0%)
Unknown0 (0.0%)
Required1 (50.0%)
Privileges Required
Low2 (100.0%)
High0 (0.0%)
None0 (0.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2021-31643MEDIUM An XSS vulnerability exists in several IoT devices from CHIYU Technology, including SEMAC, Biosense, BF-630, BF-631, and Webpass due to a lack of sanitization on the component if.c | Jun 1, 2021 | 5.4 | 65 | NO | NO |
CVE-2021-31642MEDIUM A denial of service condition exists after an integer overflow in several IoT devices from CHIYU Technology, including BIOSENSE, Webpass, and BF-630, BF-631, and SEMAC. The vulnera | Jun 1, 2021 | 6.5 | 53 | NO | YES |
Exploit Exposure
Signals from CVEs in this product scope (2 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
1 CVE
50.0% of CVEs· 91st percentile
Social Chatter
Signals from CVEs in this product scope (2 CVEs).
Media Mentions
Signals from CVEs in this product scope (2 CVEs).
Top CNAs Publishing CVEs For Biosense
Top CWEs
Versions
No cataloged versions.